These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 12409542)

  • 1. Sex-based differences in the effect of digoxin for the treatment of heart failure.
    Rathore SS; Wang Y; Krumholz HM
    N Engl J Med; 2002 Oct; 347(18):1403-11. PubMed ID: 12409542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis.
    Adams KF; Patterson JH; Gattis WA; O'Connor CM; Lee CR; Schwartz TA; Gheorghiade M
    J Am Coll Cardiol; 2005 Aug; 46(3):497-504. PubMed ID: 16053964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of digoxin on mortality and morbidity in patients with heart failure.
    Digitalis Investigation Group
    N Engl J Med; 1997 Feb; 336(8):525-33. PubMed ID: 9036306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial.
    Shlipak MG; Smith GL; Rathore SS; Massie BM; Krumholz HM
    J Am Soc Nephrol; 2004 Aug; 15(8):2195-203. PubMed ID: 15284305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.
    DiBianco R; Shabetai R; Kostuk W; Moran J; Schlant RC; Wright R
    N Engl J Med; 1989 Mar; 320(11):677-83. PubMed ID: 2646536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
    Pitt B; Zannad F; Remme WJ; Cody R; Castaigne A; Perez A; Palensky J; Wittes J
    N Engl J Med; 1999 Sep; 341(10):709-17. PubMed ID: 10471456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.
    Packer M; Carver JR; Rodeheffer RJ; Ivanhoe RJ; DiBianco R; Zeldis SM; Hendrix GH; Bommer WJ; Elkayam U; Kukin ML
    N Engl J Med; 1991 Nov; 325(21):1468-75. PubMed ID: 1944425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.
    Feldman AM; Bristow MR; Parmley WW; Carson PE; Pepine CJ; Gilbert EM; Strobeck JE; Hendrix GH; Powers ER; Bain RP
    N Engl J Med; 1993 Jul; 329(3):149-55. PubMed ID: 8515787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
    Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure.
    Freeman JV; Yang J; Sung SH; Hlatky MA; Go AS
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):525-33. PubMed ID: 24021697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy.
    Theodoropoulos TA; Bestetti RB; Otaviano AP; Cordeiro JA; Rodrigues VC; Silva AC
    Int J Cardiol; 2008 Aug; 128(1):22-9. PubMed ID: 18258318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction.
    Deswal A; Bozkurt B
    Am J Cardiol; 2006 Apr; 97(8):1228-31. PubMed ID: 16616031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
    Singh SN; Fletcher RD; Fisher SG; Singh BN; Lewis HD; Deedwania PC; Massie BM; Colling C; Lazzeri D
    N Engl J Med; 1995 Jul; 333(2):77-82. PubMed ID: 7539890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New aspects in clinical cardiology: sex-based differences in cardiovascular morbidity and mortality].
    Jerie P
    Cas Lek Cesk; 2003; 142(4):195-6. PubMed ID: 12841118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction.
    Brophy JM; Dagenais GR; McSherry F; Williford W; Yusuf S
    Am J Med; 2004 Mar; 116(5):300-4. PubMed ID: 14984814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the economic value of digoxin therapy in congestive heart failure patients? Results from the DIG trial.
    Eisenstein EL; Yusuf S; Bindal V; Bourassa MG; Horney A; Collins JF; Mark DB;
    J Card Fail; 2006 Jun; 12(5):336-42. PubMed ID: 16762794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
    Bardy GH; Lee KL; Mark DB; Poole JE; Packer DL; Boineau R; Domanski M; Troutman C; Anderson J; Johnson G; McNulty SE; Clapp-Channing N; Davidson-Ray LD; Fraulo ES; Fishbein DP; Luceri RM; Ip JH;
    N Engl J Med; 2005 Jan; 352(3):225-37. PubMed ID: 15659722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Do we use digitalis properly in the management of elderly patients suffering from the signs of chronic heart failure?].
    Erdei F; Vendrey R; Dani G; Kovács E; Márk L; Katona A
    Orv Hetil; 2006 Oct; 147(41):1993-6. PubMed ID: 17120690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.